Rifaximin
Gobernado, M.; Ponce, J.
Revista Espanola de Quimioterapia Publicacion Oficial de la Sociedad Espanola de Quimioterapia 17(2): 141-153
2004
ISSN/ISBN: 0214-3429 PMID: 15470508 Document Number: 569966
Document emailed within 1 workday
Related Documents
Bajor, J. 2006: The use of Rifaximin in daily clinical practice Orvosi Hetilap 147(3): 139-140Sharma, P.; Sharma, B.Chander. 2010: Rifaximin treatment in hepatic encephalopathy New England Journal of Medicine 362(25): 2423-2424; Author Reply 2424-2425
Descombe, J.J.; Dubourg, D.; Picard, M.; Palazzini, E. 1994: Pharmacokinetic study of rifaximin after oral administration in healthy volunteers International Journal of Clinical Pharmacology Research 14(2): 51-56
Luttichau, U.; Arcangeli, P.; Sinapi, S. 1985: The use of Rifaximin in the treatment of acute diarrhoeal enteritis: open study Panminerva Medica 27(3): 129-132
Weinstock, L.B.; Geng, B.; Brandes, S.B. 2011: Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin Canadian Journal of Urology 18(4): 5826-5830
Sud, B.; Salvaggio, M.; Greenfield, R.; Greenfield, R.A.; Bronze, M.S. 2007: Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide Journal of the Oklahoma State Medical Association 100(7): 267-272
Scarpellini, E.; Giorgio, V.; Gabrielli, M.; Filoni, S.; Vitale, G.; Tortora, A.; Ojetti, V.; Gigante, G.; Fundarò, C.; Gasbarrini, A. 2013: Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome European Review for Medical and Pharmacological Sciences 17(10): 1314-1320
Taylor, D.N.; Bourgeois, A.L.; Ericsson, C.D.; Steffen, R.; Jiang, Z.-D.; Halpern, J.; Haake, R.; Dupont, H.L. 2006: A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea American Journal of Tropical Medicine and Hygiene 74(6): 1060-1066
Moraru, I.G.; Portincasa, P.; Moraru, A.G.; Diculescu, M.; Dumitraşcu, D.L. 2013: Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. a pilot study Romanian Journal of Internal Medicine 51(3-4): 143-147
Hasan, S.; Datta, S.; Bhattacherjee, S.; Banik, S.; Saha, S.; Bandyopadhyay, D. 2018: A Randomized Controlled Trial Comparing the Efficacy of a Combination of Rifaximin and Lactulose with Lactulose only in the Treatment of Overt Hepatic Encephalopathy Journal of the Association of Physicians of India 66(1): 32-36